Assessment of Norwegian physicians’ knowledge, experience and attitudes towards medical cannabis

Figures & data

Table 1. Physicians’ perceived knowledge on central medical cannabis-related topics.

	Very little extent		Little extent		Neutral		Great extent		Very great extent
	n	%	n	%	n	%	n	%	n	%	Mean	SD (+/−)
To what extent are you familiar with the endocannabinoid system?	43	43	32	32	19	19	5	5	1	1	1.8	0.9
To what extent are you familiar with the legislation on medical cannabis in Norway	43	42.5	33	32.6	18	17.8	6	5.9	1	0.9	1.9	0.9
To what extent are you familiar with the process of prescribing medical cannabis in Norway?	53	51.9	38	37.2	9	8.8	1	0.9	1	0.9	1.6	0.7
To what extent are you familiar with the dosage of medical cannabis?	64	62.7	23	23.4	8	7.8	2	1.9	1	0.9	1.5	0.8
To what extent are you familiar with the adverse effects of cannabis?	4	3.9	24	23.5	37	36.2	33	32.3	4	3.9	3.1	0.9

Table 2. Physicians’ concerns about medical cannabis and its applicability.

	Strongly disagree		Disagree		Neither agree nor disagree		Agree		Strongly agree
	n	%	n	%	n	%	n	%	n	%	Mean	SD (+/−)
Cannabis is a legitimate treatment option.	19	18.6	9	8.8	29	28.4	22	21.5	23	22.5	3.2	1.3
Physicians in Norway should receive more education on medical cannabis.	6	5.8	5	4.9	19	18.6	38	37.2	34	33.3	3.8	1.1
Medical cannabis may reduce unnecessary use of opioids in patients with chronic pain.	7	6.8	6	5.8	49	48.0	28	27.4	12	11.7	3.3	0.9
Cannabis should be available by prescription in Norway.	17	16.8	12	11.8	40	39.6	15	14.8	17	16.8	3.0	1.2
Physicians in Norway should have significant influence on future changes in legislation regarding medical cannabis.	3	2.9	4	3.9	21	20.5	35	34.3	39	38.2	4.0	1.0